In the News
CHC’s Dr. Amy Vander Woude talks patient care amidst COVID-19 on FOX 17
04/13/2020
Cancer and Hematology Centers of Western Michigan (CHC)’s Amy Vander Woude, MD, spoke with FOX 17 Morning News this morning about CHC’s dedication to quality patient care during COVID-19. To see the interview, click the link below. Watch the Video Read more »
CHCWM named one of Nation’s Best and Brightest Companies to Work For® for second year in a row
02/06/2020
Cancer and Hematology Centers of Western Michigan (CHCWM) has been named one of the Nation’s Best and Brightest Companies to Work For® for the second year in a row. CHCWM was one of 540 winning companies selected out of 5,000 Read more »
CHCWM clinical trial published in esteemed lung cancer journal
01/22/2020
Cancer & Hematology Centers of Western Michigan (CHCWM)’s ongoing ADRIATIC clinical trial study design and eligibility was recently published in leading academic journal, Clinical Lung Cancer. ADRIATIC is the first international phase III trial studying the benefit of immunotherapy as consolidation Read more »
CHCWM oncologist Sreenivasa Chandana, M.D., Ph.D., publishes article in ‘Journal of Gastrointestinal Oncology’
10/28/2019
Cancer and Hematology Centers of Western Michigan (CHCWM) oncologist Sreenivasa Chandana, M.D., Ph.D., is one of six authors of “Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database,” which was published in Journal of Gastrointestinal Read more »
RCWM featured on Wood TV8’s eightWest
10/18/2019
Rheumatology Centers of Western Michigan (RCWM)’s Dr. Philip Velderman and Dr. Lakshmi Kocharla were featured on Wood TV8’s eightWest show on Oct. 18, 2019. To see our two physicians talk about Cancer and Hematology Centers of Western Michigan (CHCWM)’s newest Read more »
CHCWM clinical trial published in esteemed medical journal
10/09/2019
One of the oldest, most prestigious medical journals, The Lancet, recently published AstraZeneca’s Phase III CASPIAN trial, of which Cancer and Hematology Centers of Western Michigan (CHCWM) was a leading site. CASPIAN showed that Imfinzi (an anti-PDL1 immunotherapy from AstraZeneca), in combination Read more »